SREBF1 and metabolic dysfunction-associated steatotic liver disease: MiR-335-5p has been identified as a possible biomarker of non-alcoholic fatty liver disease, modulating genes involved in lipid metabolism, such as peroxisome proliferator-activated receptor-γ (PPAR-γ) and sterol regulatory element-binding protein1c (SREBP1c) [77].